Individuals with type 2 diabetes (DM2) may be less successful at achieving therapeutic weight loss than their counterparts without diabetes. This study compares weight loss in a cohort of adults with ...

For those who thought Ozempic would spell the end of diet programs, think again. WeightWatchers this week launched WeightWatchers GLP-1, a subscription program focused on the health and nutrition ...

Allurion Technologies, a weight-loss platform, launched AllurionMeds to give patients GLP-1 medications for weight loss combined with its AI-enabled Coach Iris platform. The company aims to advance ...